Product Information
AMLODIPINE-ATORVAST 5-40 MG is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.4181 per EA under NDC 00378451593. Its NADAC has been published 604 times since Dec 3, 2014.
Strength
5; 40 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378451593
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA200465On Market Since
10/16/2014
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-ATORVAST 5-40 MG has been published 604 times since Dec 3, 2014, and over the history we have for it it has declined 76.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4181 per EA |
|---|---|
| All-time high | $6.5690 (Sep 16, 2015) |
| All-time low | $1.4181 (Jun 17, 2026) |
| 52-week high | $2.2684 |
| 52-week low | $1.4181 |
| Median price | $3.9748 |
| Average price | $3.6853 |
| Largest weekly change | +58.2% (Feb 22, 2023) |
| Weeks tracked | 604 |
| Tracking since | Dec 3, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Amlodipine and atorvastatin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AMLODIPINE-ATORVAST 5-40 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 5-40 MG, manufactured by Mylan Pharmaceuticals Inc., is $1.4181 per EA (NDC 00378451593), effective Jun 24, 2026.
How has the price of AMLODIPINE-ATORVAST 5-40 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 5-40 MG has declined 76.4%. It has been tracked across 604 weekly CMS publications since Dec 3, 2014.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 5-40 MG?
Since Dec 3, 2014, the NADAC for AMLODIPINE-ATORVAST 5-40 MG has ranged from a low of $1.4181 (Jun 17, 2026) to a high of $6.5690 (Sep 16, 2015), with a median of $3.9748 per EA.
Are there cheaper alternatives to AMLODIPINE-ATORVAST 5-40 MG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AMLODIPINE-ATORVAST 5-40 MG, so no direct lower-cost alternative is listed.
Who manufactures AMLODIPINE-ATORVAST 5-40 MG?
AMLODIPINE-ATORVAST 5-40 MG (NDC 00378451593) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification